Most contemporary drug discovery companies (sponsors) outsource some (or all) drug development to external contract partners, eg. Contract Research Organisations (CROs) and/or Contract Development and Manufacturing Organisations (CDMOs). Communication between sponsor and contract organisation is largely done via email and poorly structured Excel reports which is a highly manual, inefficient, and error-prone process. Additionally, sponsors of contracted work struggle with a common set of problems and challenges including:

• Prioritising and communicating the work to the CRO 
• Onboarding and offboarding CRO resources
• Tracking the work at the CRO  
• Masking proprietary information from the CRO to preserve the sponsor's intellectual property  
• Integrating the data from the CRO into the corporate data management systems  
  
  Historically each sponsor has been isolated to solve these problems on their own, costing time and money, but recently we announced a new capability being delivered in 2024 by Revvity Signals as an add-on to Signals Notebook and Signals Research Suite. This new product will leverage the Signals Platform and solve the common problems plaguing the standard sponsor-CRO interactions.

An audience Q&A session with the presenters follows the webinar presentations.

Watch the webinar on-demand now!